Le syndrome de lyse tumorale biologique chez les patients atteints d’hémopathies malignes

Simple item page
dc.contributor.advisorM. HARIF
dc.contributor.authorLamia OULKADI
dc.date.accessioned2023-09-19T14:00:43Z
dc.date.accessioned2026-01-28T12:19:02Z
dc.date.available2023-09-19T14:00:43Z
dc.date.issued2015
dc.description.collaboratorL. CHABAA
dc.description.collaboratorJ. EL HOUDZI
dc.description.collaboratorW. FADILI
dc.identifier.urihttps://toubkal.imist.ma/handle/123456789/20451
dc.identifier.urihttps://doi.org/10.83129/toubkal-2200
dc.language.isofr
dc.publisherFaculté de Médecine et de Pharmacie, Marrakechfr_FR
dc.publisherSciences médicalesfr_FR
dc.subject.otherHématologie, Biochimie
dc.subject.specificChimiothérapie
dc.subject.specifichémopathies malignes
dc.subject.specificinsuffisance rénale
dc.subject.specificsyndrome de lyse tumorale
dc.titleLe syndrome de lyse tumorale biologique chez les patients atteints d’hémopathies malignesfr_FR

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
these26-15.pdf
Size:
1.39 MB
Format:
Adobe Portable Document Format
Download

Collections

Faculté de Médecine et de Pharmacie - Marrakech